GSK and Zhifei partner to co-promote Shingrix vaccine in China
LONDON, UK: GSK plc (LSE/NYSE: GSK) has announced an exclusive agreement with Chongqing Zhifei Biological Products, Ltd. (Zhifei) to co-promote its shingles vaccine, Shingrix, in China for an initial three-year period. The partnership aims to significantly extend the availability and…